SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,156 | -14.0% | 28,660 | -6.3% | 0.01% | -9.1% |
| Q2 2023 | $919,024 | -21.1% | 30,573 | -4.9% | 0.01% | -26.7% |
| Q1 2023 | $1,164,867 | -54.4% | 32,152 | -55.1% | 0.02% | -11.8% |
| Q4 2022 | $2,556,612 | +68.5% | 71,674 | +59.9% | 0.02% | -22.7% |
| Q3 2022 | $1,517,000 | +15.4% | 44,812 | -1.4% | 0.02% | +29.4% |
| Q2 2022 | $1,315,000 | -18.8% | 45,460 | -9.2% | 0.02% | -5.6% |
| Q1 2022 | $1,619,000 | +10.5% | 50,080 | -0.3% | 0.02% | +20.0% |
| Q4 2021 | $1,465,000 | – | 50,235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |